Sullivan Christopher Ryan
Chief Financial Officer
CIK: 1810417
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Apr 2, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 6,200 | $17.02 | $105,553.14 | View Details Filing |
| Apr 2, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 1,780 | $17.57 | $31,269.97 | View Details Filing |
| Apr 1, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 7,479 | $16.83 | $125,840.91 | View Details Filing |
| Apr 1, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 500 | $15.86 | $7,929.00 | View Details Filing |